Clofarabine, Cytarabine, and Thymoglobulin for Allogeneic Transplantation
Status:
Terminated
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
This study will test the combination of clofarabine, cytarabine, and thymoglobulin as a
non-myeloablative conditioning regimen for patients with myelodysplastic syndromes or acute
myeloid leukemia undergoing allogeneic stem cell transplant.